Abstract
A procedure for preparing high-radiochemical-purity 125I-salbutamol was developed in order to characterize the binding properties of β2-adrenoceptors. Direct radioiodination of salbutamol was carried out using Chloramine T as an oxidizing agent. The optimized conditions for salbutamol labeling with 125I are as follows: 100 μg of salbutamol, 50 μg of Chloramine T, 150 μl of phosphate buffer (pH 7), room temperature (25 ± 1°C), 5 min. The radiochemical yield of up to 98% was attained. The radiochemical yield and purity of the labeled product were evaluated by electrophoresis and HPLC. Biodistribution studies were carried out in normal Albino Swiss mice at different time intervals after administration of 125I-salbutamol. The results indicate that the labeled compound cleared from the systematic circulation within 3 h after administration and majority of organs showed significant decrease in the 125I-salbutamol uptake. The heart and lung uptake was high. 125I-Salbutamol can be used as β-receptor imaging agent.
Similar content being viewed by others
References
Amin, A.M., Mohamed, S.B., Moselhy, S.S., and Borai, I.H., Arab J. Nucl. Sci. Appl., 2009, vol. 42, no. 2, p. 33.
Brines, P.J., The Lung, Crystal, R.G. and West, J.B., Eds., Philadelphia: Raven, 1997, p. 1269.
Kurosaka, F. and Nishio, H., Allergol. Int., 2009, vol. 58, no. 4, p. 1.
Dolovich, M.B., J. Aerosol Med., 2001, vol. 14, p. 35.
Aigbirhio, F., Pike, V.W., Francotte, E., et al., J. Label. Compd. Radiopharm., 1992, vol. 31, p. 159.
Elsinga, P.H., Waarde, A. van, Jaeggi, K.A., et al., J. Med. Chem., 1997, vol. 40, p. 3829.
Elsinga, P.H., Waarde, A. van, Doze, P., et al., J. Nucl. Med., 1999, vol. 40, p. 87.
Visser, T.J., Waarde, A. van, Mark, T.W. van der, et al., J. Nucl. Med., 1997, vol. 38, p. 196.
Berridge, M.S., Nelson, A.D., Zheng, L.B., et al., J. Nucl. Med., 1994, vol. 35, p. 1665.
Berges, R., Segura, J., De La Torre, X., and Ventura, R., J. Chromatogr. B: Biomed. Appl., 1999, vol. 723, p. 173.
Mohammadi, A., Alizadeh, T., Dinarvand, R., et al., Asian J. Chem., 2009, vol. 21, no. 4, p. 2875.
Soif-Vranif, T., Bobinac, D., Bajek, S., et al., Braz. J. Med. Biol. Res., 2005, vol. 38, no. 12, p. 1799.
El-Shaboury, G. and El-Tawoosy, M., J. Radioanal. Nucl. Chem., 2002, vol. 252, no. 1, p. 109.
El-Shaboury, G., Farah, K., and El-Tawoosy, M., J. Radioanal. Nucl. Chem., 2001, vol. 249, no. 3, p. 535.
Baldwin, R.M., Int. J. Appl. Radiat. Isot., 1986, vol. 37, no. 8, p. 817.
March, J., Advanced Organic Chemistry: Reactions, Mechanisms, and Structure, New York: Wiley, 1992, 4th ed.
Shafik, H.M., J. Radioanal. Nucl. Chem., 2009, vol. 281, no. 3, p. 639.
Sallam, Kh.M. and Mehany, N.L., J. Radioanal. Nucl. Chem., 2009, vol. 281, no. 3, p. 329.
Amin, A.M., Soliman, S.E., Killa, H.M., and El-Aziz, H.A., J. Radioanal. Nucl. Chem., 2010, vol. 283, no. 2, p. 273.
El-Ghany, E.A., Farouk, N., and El-Kolaly, M.T., J. Radioanal. Nucl. Chem., 2000, vol. 245, no. 2, p. 243.
Slabert, J.P., Langerhoven, J.H., and Smit, B.S., J. Radioanal. Nucl. Chem., 1999, vol. 240, no. 2, p. 505.
Fraker, P.J. and Speck, J.C., J. Biochem. Biophys. Res. Commun., 1978, vol. 80, p. 849.
Danforth, E. and Himms-Hagen, J., Eur. J. Endocrinol., 1997, vol. 136, p. 362.
Pinguet, F., Culine, S., Bressolle, F., et al., Clin. Cancer Res., 2000, vol. 6, p. 57.
Korde, A., Venkatesh, M., and Sarma, H.D., in Int. Symp. on Modern Trends in Radiopharmaceuticals for Diagnosis and Therapy, Lisbon (Portugal), March 30–April 3, 1998, IAEA, SM-355/13.
Knust, E.J., Dutschka, K., and Machulla, H.J., J. Radioanal. Nucl. Chem. Lett., 1990, vol. 144, p. 107.
Cynthia, B.F., Roger, K.D., Kaumann, A.J., et al., J. Mol. Pharmacol., 1979, vol. 12, p. 328.
Saccavini, J.C. and Bruneau, C., IAEA CN, 1984, no. 4519, p. 153.
Rayudu, G.V.S., Radiotracers for Medical Application, vol. 11 of CRS Ser. on Radiotracers in Biology and Medicine, 1983.
El-Mouhty, N.R.A., Attallah, K.M., El-Tawoosy, M., and El-Kolaly, M.T., Arab. J. Nucl. Sci. Appl., 2008, vol. 41, no. 3, p. 29.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Russian in Radiokhimiya, 2012, Vol. 54, No. 4, pp. 369–373.
The text was submitted by the authors in English.
Rights and permissions
About this article
Cite this article
El-Tawoosy, M., Ibrahim, I.T. Radioiodination and biological evaluation of salbutamol as a β2-adrenoceptor agonist. Radiochemistry 54, 401–406 (2012). https://doi.org/10.1134/S1066362212040169
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1066362212040169